Revenue | ₹1.52Cr |
Net Profits | ₹-1.29Cr |
Net Profit Margins | -84.87% |
Vista Pharmaceuticals Ltd’s revenue fell -18.72% since last year same period to ₹1.52Cr in the Q1 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -56.2% fall in its revenue since last 3-months.
Vista Pharmaceuticals Ltd’s net profit fell -50% since last year same period to ₹-1.29Cr in the Q1 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 14% jump in its net profits since last 3-months.
Vista Pharmaceuticals Ltd’s net profit margin fell -84.54% since last year same period to -84.87% in the Q1 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -96.33% fall in its net profit margins since last 3-months.
The revenue for Vista Pharmaceuticals Ltd in the Q1 results 2025 was ₹1.52Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q1 results 2025 was ₹-1.29Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q1 results 2025 was -84.87%.
The revenue for Vista Pharmaceuticals Ltd in the Q1 results 2024 was ₹1.87Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.86Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q1 results 2024 was -45.99%.